In a first for China, Neuracle’s implantable brain-computer interface wins approval

South China Morning PostCenter-RightEN 1 min read 100% complete by Julie ZhangMarch 13, 2026 at 10:30 AM
In a first for China, Neuracle’s implantable brain-computer interface wins approval

AI Summary

short article 1 min

Neuracle Medical Technology has received China's first approval for an implantable brain-computer interface (BCI) system. The device aims to restore hand motor function in patients with spinal cord injuries. This regulatory milestone highlights China's growing neurotechnology sector, with domestic BCI companies emerging as potential competitors to firms like Neuralink. Neuracle's system, a coin-sized wireless device placed on the brain's surface, reads neural signals and translates them into hand movements. The approval marks the first time globally that an invasive BCI can be commercially sold and used on patients. Neuracle, which also develops scientific research equipment, recently began its listing process on the Shanghai Stock Exchange.

Keywords

brain-computer interface 100% bci 90% neuracle 80% spinal cord injuries 70% neurotechnology 60% regulatory approval 60% china 50% hand motor function 50% implantable device 40%

Sentiment Analysis

Very Positive
Score: 0.70

Source Transparency

Source
South China Morning Post
Political Lean
Center-Right (0.50)
Far LeftCenterFar Right
Classification Confidence
90%
Geographic Perspective
China

This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).

Topic Connections

Explore how the topics in this article connect to other news stories

No topic relationship data available yet. This graph will appear once topic relationships have been computed.
Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.